牛牛AI助理已提取核心訊息
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by Transcode Therapeutics, Inc. effective as of January 18, 2024, at 1:00 P.M. The Form S-1 is a registration statement that companies use to register their securities before they can be offered to the public. The effectiveness of this form indicates that Transcode Therapeutics has met all the necessary regulatory requirements to proceed with its public offering.
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by Transcode Therapeutics, Inc. effective as of January 18, 2024, at 1:00 P.M. The Form S-1 is a registration statement that companies use to register their securities before they can be offered to the public. The effectiveness of this form indicates that Transcode Therapeutics has met all the necessary regulatory requirements to proceed with its public offering.
美國證券交易委員會（SEC）宣佈，Transcode Therapeutics, Inc.提交的S-1表格自2024年1月18日下午1點起生效。S-1表格是公司在向公衆發行證券之前用來註冊證券的註冊聲明。該表格的有效性表明，Transcode Therapeutics已經滿足了進行公開募股的所有必要監管要求。
美國證券交易委員會（SEC）宣佈，Transcode Therapeutics, Inc.提交的S-1表格自2024年1月18日下午1點起生效。S-1表格是公司在向公衆發行證券之前用來註冊證券的註冊聲明。該表格的有效性表明，Transcode Therapeutics已經滿足了進行公開募股的所有必要監管要求。
有用
沒用